Quarterly rpt on consolidated results for the financial period ended 31/3/2009

PHARMANIAGA BERHAD

Financial Year End

31/12/2009
Quarter1
Quarterly report for the financial period ended31/03/2009
The figureshave not been audited

Attachments

1Q2009.pdf
57 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/03/2009

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/03/2009
31/03/2008
31/03/2009
31/03/2008
RM'000
RM'000
RM'000
RM'000
1Revenue
313,716
309,650
313,716
309,650
2Profit/(loss) before tax
20,184
27,374
20,184
27,374
3Profit/(loss) for the period
14,693
18,982
14,693
18,982
4Profit/(loss) attributable to ordinary equity holders of the parent
14,522
18,545
14,522
18,545
5Basic earnings/(loss) per share (sen)
13.57
17.34
13.57
17.34
6Proposed/Declared dividend per share (sen)
0.00
0.00
0.00
0.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.7600
3.6300

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced8 May 2009  
CategoryFinancial Results
Reference NoPB-090505-61947